Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

A patient with complete hair loss regrew all her hair using tofacitinib.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Drug repurposing shows promise for treating many medical conditions.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The medication lopinavir-ritonavir may cause severe hair loss.